AAAAAA
Results: 1-25/59
Authors:
LUSHER JM
HILLMANWISEMAN C
HURST D
Citation: Jm. Lusher et al., IN-VIVO RECOVERY WITH PRODUCTS OF VERY HIGH-PURITY - ASSAY DISCREPANCIES, Haemophilia, 4(4), 1998, pp. 641-645
Authors:
LUSHER JM
Citation: Jm. Lusher, RECOMBINANT ACTIVATED FACTOR-VII FOR TREATMENT OF INTRAMUSCULAR HEMORRHAGES - A COMPARISON OF EARLY VERSUS LATE TREATMENT, Blood coagulation & fibrinolysis, 9, 1998, pp. 111-114
Authors:
WARRIER I
LUSHER JM
Citation: I. Warrier et Jm. Lusher, DEVELOPMENT OF ANAPHYLACTIC SHOCK IN HEMOPHILIA-B PATIENTS WITH INHIBITORS, Blood coagulation & fibrinolysis, 9, 1998, pp. 125-128
Authors:
SHAPIRO AD
WHITE GC
KIM HC
LUSHER JM
BERGMAN GE
Citation: Ad. Shapiro et al., EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN HEMOPHILIA-B PATIENTS UNDERGOING SURGICAL-PROCEDURES, Haemophilia, 3(4), 1997, pp. 247-253
Authors:
WARRIER I
BAIRDCOX K
LUSHER JM
Citation: I. Warrier et al., USE OF CENTRAL VENOUS CATHETERS IN CHILDREN WITH HEMOPHILIA - ONE HEMOPHILIA TREATMENT CENTER EXPERIENCE, Haemophilia, 3(3), 1997, pp. 194-198
Authors:
WARRIER I
EWENSTEIN BM
KOERPER MA
SHAPIRO A
KEY N
DIMICHELE D
MILLER RT
PASI J
RIVARD GE
SOMMER SS
KATZ J
BERGMANN F
LJUNG R
PETRINI P
LUSHER JM
Citation: I. Warrier et al., FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B, Journal of pediatric hematology/oncology, 19(1), 1997, pp. 23-27
Authors:
WARRIER I
LUSHER JM
Citation: I. Warrier et Jm. Lusher, RECOMBINANT (R) FVIIA (NOVOSEVEN) FOR TREATMENT OF BLEEDING EPISODES IN CHILDREN WITH HEMOPHILIA-B COMPLICATED BY INHIBITOR ANTIBODIES AND ANAPHYLAXIS TO F-IX PRODUCTS, Thrombosis and haemostasis, 1997, pp. 201-201
Authors:
LUSHER JM
Citation: Jm. Lusher, PROPHYLAXIS IN CHILDREN WITH HEMOPHILIA - IS IT THE OPTIMAL TREATMENT, Thrombosis and haemostasis, 78(1), 1997, pp. 726-729
Authors:
WHITE GC
COURTER S
BRAY GL
LEE M
GOMPERTS ED
WHITE G
COOPER H
HAIRE W
BRETTLER D
KISKER T
HOOTS K
SHAPIRO A
HALIE MR
MANNUCCI PM
SCHARRER I
BRACKMANN HH
GORDON EM
GOLDSMITH J
HILGARTNER M
GILL J
LAURIAN Y
LARRIEU Y
KESSLER C
PAI MKR
LUSHER JM
NEUFELD E
EWENSTEIN B
SCHULMAN S
MORFINI M
ADDIEGO JE
VERMYLEN JG
KRILL CE
INGERSLEV J
Citation: Gc. White et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA-A, Thrombosis and haemostasis, 77(4), 1997, pp. 660-667
Authors:
HOOTS K
LUSHER JM
MANCOJOHNSON M
POWELL JS
RAGNI M
CONSTANT J
HURST D
Citation: K. Hoots et al., PHASE-I PHARMACOKINETIC CROSSOVER TRIAL OF RECOMBINANT FVIII AND A NEW SUCROSE-FORMULATED RECOMBINANT FVIII, Blood, 90(10), 1997, pp. 3184-3184
Authors:
LUSHER JM
SPIRA J
Citation: Jm. Lusher et J. Spira, SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) TREATED EXCLUSIVELY WITH RECOMBINANT B-DOMAIN DELETED F-VIII (RVIII-SQ) - 2.5 STUDY YEARS, Blood, 90(10), 1997, pp. 2664-2664
Authors:
BUCHANAN GR
DEALARCON PA
FEIG SA
GILCHRIST GS
LUKENS JN
MOERTEL CL
COHEN AR
DICKERMAN JD
FORMAN EN
GLADER BE
LUSHER JM
Citation: Gr. Buchanan et al., ACUTE IDIOPATHIC THROMBOCYTOPENIC PURPURA - MANAGEMENT IN CHILDHOOD, Blood, 89(4), 1997, pp. 1464-1465
Authors:
WARRIER I
EWENSTEIN BM
KOERPER MA
SHAPIRO A
KEY N
DIMICHELE D
MILLER RT
PASI J
RIVARD GE
SOMMER SS
BERGMANN F
LUSHER JM
Citation: I. Warrier et al., FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B, Haemophilia, 2(4), 1996, pp. 259-260
Authors:
ONWUZURIKE N
WARRIER I
LUSHER JM
Citation: N. Onwuzurike et al., TYPES OF BLEEDING SEEN DURING THE FIRST 30 MONTHS OF LIFE IN CHILDRENWITH SEVERE HEMOPHILIA-A AND HEMOPHILIA-B, Haemophilia, 2(3), 1996, pp. 137-140
Authors:
LUSHER JM
Citation: Jm. Lusher, RECOMBINANT CLOTTING FACTOR CONCENTRATES, Bailliere's clinical haematology, 9(2), 1996, pp. 291-303
Authors:
TAUB JW
WARRIER I
LUSHER JM
HOLTKAMP C
BEARDSLEY DS
Citation: Jw. Taub et al., ANTIPLATELET ANTIBODIES IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA - REPLY, American journal of hematology, 51(4), 1996, pp. 328-328
Authors:
SHAPIRO AD
RAGNI MV
LUSHER JM
CULBERT S
KOERPER MA
BERGMAN GE
HANNAN MM
Citation: Ad. Shapiro et al., SAFETY AND EFFICACY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 75(1), 1996, pp. 30-35
Authors:
LUSHER JM
Citation: Jm. Lusher, RECOMBINANT FACTOR-VIIA (NOVOSEVEN(R)) IN THE TREATMENT OF INTERNAL BLEEDING IN PATIENTS WITH FACTOR-VII AND FACTOR-IX INHIBITORS, Haemostasis, 26, 1996, pp. 124-130
Authors:
LUSHER JM
SARNAIK S
Citation: Jm. Lusher et S. Sarnaik, HEMATOLOGY, JAMA, the journal of the American Medical Association, 275(23), 1996, pp. 1814-1815
Authors:
LUSHER JM
HILLMANWISEMAN C
SIMPSON P
HURST D
Citation: Jm. Lusher et al., PLASMA FVIII LEVELS MEASURED AFTER INFUSION OF RECOMBINANT-F-VIII (RFVIII) VARY SIGNIFICANTLY WITH DIFFERENT ASSAY-METHODS - (WILL THE REALFVIII LEVEL PLEASE STAND UP), Pediatric research, 39(4), 1996, pp. 934-934
Authors:
WARRIER I
LUSHER JM
Citation: I. Warrier et Jm. Lusher, SIMULTANEOUS APPEARANCE OF FACTOR (F) IX INHIBITOR DEVELOPMENT AND ANAPHYLAXIS FOLLOWING INFUSION OF FIX CONCENTRATES IN CHILDREN WITH SEVERE HEMOPHILIA (H) B, Pediatric research, 39(4), 1996, pp. 964-964
Authors:
MENACHE D
ARONSON DL
DARR F
MONTGOMERY RR
GILL JC
KRESSLER CM
LUSHER JM
PHATAK PD
SHAPIRO AD
THOMPSON AR
WHITE GC
Citation: D. Menache et al., PHARMACOKINETICS OF VON-WILLEBRAND-FACTOR AND FACTOR-VIIIC IN PATIENTS WITH SEVERE VON-WILLEBRAND DISEASE (TYPE-3 VWD) - ESTIMATION OF THE RATE OF FACTOR-VIIIC SYNTHESIS, British Journal of Haematology, 94(4), 1996, pp. 740-745
Authors:
WARRIER I
LUSHER JM
Citation: I. Warrier et Jm. Lusher, RECOMBINANT (R) FACTOR VIIA (NOVOSEVEN) IS ME MOST APPROPRIATE TREATMENT FOR CHILDREN WITH HEMOPHILIA-B COMPLICATED BY INHIBITOR ANTIBODIESAND ANAPHYLAXIS TO F IX CONTAINING PRODUCTS, Blood, 88(10), 1996, pp. 1756-1756
Authors:
LUSHER JM
Citation: Jm. Lusher, CASE PRESENTATION - A PATIENT WITH VON-WILLEBRAND DISEASE WITH MENORRHAGIA - ADDITIONAL COMMENT, American journal of obstetrics and gynecology, 175(3), 1996, pp. 765-765
Authors:
LUSHER JM
Citation: Jm. Lusher, SCREENING AND DIAGNOSIS OF COAGULATION DISORDERS, American journal of obstetrics and gynecology, 175(3), 1996, pp. 778-783